Cognitive Impairment and Dementia in Patients with Parkinson Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|10|903-912

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.10, 2009-07, pp. : 903-912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia

By Willan Andrew R.  

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 93-106

Adis International

Access to resources Recommend Favorite

Rivastigmine in Parkinson's disease dementia

By Chitnis Shilpa   Rao Jayaraman  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 941-955

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: In Parkinson's Disease Dementia

By Siddiqui M. Asif A.   Wagstaff Antona J.  

CNS Drugs, Vol. 20, Iss. 9, 2006-01 ,pp. : 739-747

Adis International

Access to resources Recommend Favorite

Treatment of Dementia with Lewy Bodies and Parkinson's Disease Dementia

By Ballard Clive  

Drugs & Aging, Vol. 28, Iss. 10, 2011-10 ,pp. : 769-777

Adis International

Access to resources Recommend Favorite

Comparison of Hippocampal Volume Measured Using Magnetic Resonance Imaging in Alzheimer's Disease, Vascular Dementia, Mild Cognitive Impairment and Pseudodementia

By Dolek N   Saylisoy S   Ozbabalik D   Adapinar B  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 717-725

Field House Publishing

Access to resources Recommend Favorite